D-Dimer Peak has been previously described as an important potential early biomarker in COVID-19, mainly when related to coagulation disorders and liver function [41, 42]; the same was observed for C-Reactive Protein [43–45], which was also early increased even before disease progression to severe COVID-19. This evidence concerns the gene CRP and blood coagulation disease.